fbpx

Female, 58 y/o

Patient internal ID: 21850161

ICD-10 code

C50.8 Malignant Neoplasm of Overlapping Lesions of Breast

Diagnosis (incl metastases/stage) and year

March 2014
Left Breast Carcinoma pT2(2) N0M0 LV1 R0 G2 ER (+) PR (+) HER2(0) KI67 45%. Disease progression in April 2020 – Metastasis in Liver, Pleura, Lung, Diaphragm, and Bone.

Previous treatment

Surgery (Mastectomy), Chemotherapy (AC-Paclitaxel), Hormone Therapy (Tamoxifen), Radiation Therapy, Chemotherapy (Paclitaxel + Gemcitabine), Chemotherapy (Docetaxel + Capecitabine), Chemotherapy (Abemaciclib + Fulvestrant).

Prognosis and survival expectation

The prognosis remains poor for Advanced Breast Cancer, with a median survival of ~32 months from diagnosis.

Treatment provided

Autologous DCV (7 doses) and CIK (4 doses) over a period of 5 months.

Patient survival/condition and year

The patient has survived for almost 10 years and 44 months since the disease progression. It can be concluded that the addition of Immunotherapy, alongside Surgery, Radiation Therapy, Chemotherapy and Hormone therapy, has benefited patient in disease stabilisation and extended patient survival by an estimate of around 12 months so far.

Date of Review

30/12/2023